Comparison of Deferasirox and Desferoxamine in Patients of β-Thalassemia Major With Iron Overload
Clinical trial NCT06468423 · COMPLETED
Trial details
- NCT number
- NCT06468423
- Sponsor
- RESnTEC, Institute of Research
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2023-09-30
- Enrollment
- 142
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.